Literature DB >> 8761339

Stability study on renal type I mineralocorticoid receptor.

M D Galigniana1.   

Abstract

The purpose of this work is to review stability and activation properties of type I receptor, in order to explain the reasons for its extreme in vitro instability. We demonstrate that the treatment of rat kidney cytosol with H2O2 prevents aldosterone binding, DNA/steroid-receptor complex interactions, and prevents the receptor thermal inactivation. In contrast, exogenous sulfhydryl reducing reagents are necessary to insure maximum binding of mineralocorticoid receptor and DNA/steroid-receptor interaction. However, the presence of beta-mercaptoethanol in thermal induced incubations reverts the H2O2 protection. We also demonstrate that contaminations with free or sequestered iron are harmful for both, receptor binding capacity (in a reversible form) and for hormone-receptor/DNA binding properties (in a partially reversible form). We propose a sulfhydryl oxidative mechanism for type I mineralocorticoid receptor inactivation in which iron contaminants might accelerate this process by oxidative catalysis. We also demonstrate that when thiol groups are blocked by specific reagents such as N-ethyl-maleimide or dithionitrobenzoic acid, type I sites loose binding capacity, but the protein is protected from oxidation as well as inactivation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8761339     DOI: 10.1016/0024-3205(96)00331-1

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  5 in total

1.  Comparative inhibition by hard and soft metal ions of steroid-binding capacity of renal mineralocorticoid receptor cross-linked to the 90-kDa heat-shock protein heterocomplex.

Authors:  M D Galigniana; G Piwien-Pilipuk
Journal:  Biochem J       Date:  1999-08-01       Impact factor: 3.857

Review 2.  Modulation of nuclear receptor function by cellular redox poise.

Authors:  Eric L Carter; Stephen W Ragsdale
Journal:  J Inorg Biochem       Date:  2014-01-21       Impact factor: 4.155

3.  Purification and characterization of recombinant human mineralocorticoid receptor.

Authors:  Colin D Clyne; Ching-Yi Chang; Rachid Safi; Peter J Fuller; Donald P McDonnell; Morag J Young
Journal:  Mol Cell Endocrinol       Date:  2008-12-09       Impact factor: 4.102

4.  Native rat kidney mineralocorticoid receptor is a phosphoprotein whose transformation to a DNA-binding form is induced by phosphatases.

Authors:  M D Galigniana
Journal:  Biochem J       Date:  1998-08-01       Impact factor: 3.857

5.  The novel mineralocorticoid receptor antagonist finerenone attenuates neointima formation after vascular injury.

Authors:  Jochen Dutzmann; Robert-Jonathan Musmann; Marco Haertlé; Jan-Marcus Daniel; Kristina Sonnenschein; Andreas Schäfer; Peter Kolkhof; Johann Bauersachs; Daniel G Sedding
Journal:  PLoS One       Date:  2017-09-19       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.